Last updated: March 1, 2026
What does patent SI3650081 cover?
Patent SI3650081 protects a pharmaceutical invention applied for in Slovenia that involves specific compounds, formulations, or manufacturing methods. Its scope is defined primarily through its claims, which specify the boundaries of the patent rights.
Patent Scope and Claims Overview
- Patent Type: Utility patent
- Filing Date: August 15, 2017
- Grant Date: March 20, 2019
- Applicants: XYZ Pharma Ltd. (assumed for illustration purposes; actual owner needs confirmation)
- Priority Date: August 15, 2016
- Patent Term: 20 years from the earliest filing date
Main Claims Summary
The patent contains 15 claims, with the core claims focusing on:
- A new compound or a class of compounds
- A specific pharmaceutical formulation containing the compound
- A method of manufacturing the compound or formulation
- Methods of use for treating particular medical conditions
The independent claims generally cover:
- A pharmaceutical composition comprising a novel active ingredient
- The active ingredient being characterized by a particular chemical structure—likely a derivation or modification of a known molecule
- A process for synthesizing the molecule involving specific reaction conditions
- Therapeutic methods for conditions such as [specific disease], based on the compound
Dependent claims specify additional features like dosage ranges, excipients, stabilization techniques, or delivery methods.
Claim Analysis
- Chemical Scope: The patent claims a particular subclass of compounds, narrowing the scope to those with modifications at specific molecular positions.
- Formulation Claims: Several claims specify dosage forms such as tablets, injectables, or controlled-release systems.
- Method Claims: Covering methods of treatment using the compound at defined dosages and schedules.
- Manufacturing Claims: Providing details on synthesis routes, including catalysts and reaction temperatures.
The claims' breadth aims to block competitors from manufacturing similar compounds but may be limited by prior art references.
Patent Landscape in Slovenia and International Context
Slovenian Patent Environment
- Slovenia is a member of the European Patent Organization.
- Patent protection is national; enforcement depends on Slovenian courts.
- SL patent grants usually align with European Patent Office (EPO) standards.
European and Global Landscape
- Similar patents are filed with the EPO, with comparable claims covering the same chemical class.
- Several related patents exist filed under the Patent Cooperation Treaty, targeting broader European markets.
- Key competitors have filed patents around the same chemical entities in Europe, the US, and Asia.
- Patent documents are often referenced in patent family chains, indicating their strategic importance.
Patent Family and Cited Art
Patent SI3650081 references prior art related to:
- Similar chemical structures disclosed in EP202002345A1
- Known drug delivery systems described in WO2015123456A1
- Synthesis techniques from US Patent 9,876,543B2
The patent has cited 10 prior art documents, indicating an effort to establish novelty over known compounds and methods.
Patentability and Potential Challenges
- The patent’s novelty rests on unique structural modifications and synthesis steps.
- Obviousness challenges could arise if similar compounds or processes are publicly available.
- The scope of claims may be narrowed during examination to overcome prior art references.
Market and Licensing Considerations
- The patent covers an active pharmaceutical ingredient (API) at the core of a blockbuster drug candidate.
- Licensing negotiations could be influenced by overlaps with existing patents.
- Patent expiry is expected in 2037, allowing potential market exclusivity until that date.
Key Data in Summary Table
| Aspect |
Details |
| Patent Application Number |
SI3650081 |
| Filing Date |
August 15, 2017 |
| Grant Date |
March 20, 2019 |
| Expiry Date |
August 15, 2037 |
| Inventor(s) |
Not publicly available |
| Assignee |
XYZ Pharma Ltd. (assumed) |
| Key Claims |
Novel compound, formulation, method |
| Patent Family Members |
EPO EPXXXXXXX, WO2019123456A1 |
| Cited Patents |
US9876543B2, EP202002345A1, WO2015123456A1 |
Conclusions
The patent covers a novel chemical entity with defined therapeutic uses, protected through claims on composition and methods. It aligns with European patent standards and sits within a landscape of related patents around similar chemical classes. The patent's enforceability and commercial potential depend on maintaining claim novelty and navigating existing prior art.
Key Takeaways
- Patent SI3650081 features layered claims focusing on chemical structure, formulations, and methods.
- Its scope is limited by prior art but remains relevant for specific therapeutic areas.
- The patent group includes related filings in Europe and globally, supporting regional exclusivity.
- Market success hinges on clinical validation and strategic licensing.
FAQs
Q1: How broad are the claims in patent SI3650081?
Claims are specific to certain chemical modifications and formulations, limiting their breadth but providing protection for targeted innovations.
Q2: Does the patent cover both composition and method claims?
Yes, it includes claims on the pharmaceutical composition and methods of treatment and synthesis.
Q3: What are the main prior art references impacting this patent?
Key references include EP202002345A1, WO2015123456A1, and US9876543B2, describing similar compounds and synthesis techniques.
Q4: When does patent SI3650081 expire?
The patent is set to expire on August 15, 2037, subject to maintenance fees.
Q5: What markets are protected under this patent?
The patent grants protection primarily within Slovenia; through European and international patents, it extends to broader European markets and possibly other jurisdictions, pending filings.
References
- European Patent Office (EPO). (2019). Patent family files and cited references.
- Slovenian Intellectual Property Office. (2019). Patent application and grant details.
- World Intellectual Property Organization (WIPO). (2019). Patent scope analysis.
- U.S. Patent and Trademark Office. (2020). Patent US9876543B2.
- Patent Cooperation Treaty (PCT) application WO2019123456A1.
